Smith Kenneth J, Zimmerman Richard K, Nowalk Mary Patricia, Lin Chyongchiou J
Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Department of Family Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
J Am Geriatr Soc. 2017 Apr;65(4):763-768. doi: 10.1111/jgs.14588. Epub 2016 Dec 26.
To estimate the cost-effectiveness of an intervention to increase pneumococcal, influenza, and pertussis-containing vaccine uptake in adults aged 65 and older in primary care practices.
Markov decision analysis model, comparing the cost-effectiveness of the 4 Pillars Practice Transformation Program with no intervention.
Diverse primary care practices in two U.S. cities.
Clinical trial participants aged 65 and older.
Quality-adjusted life years (QALYs), public health outcomes, and costs. Vaccination rates and intervention costs were derived from a randomized controlled cluster trial. Other parameters were derived from the medical literature and Centers for Disease Control and Prevention data. All parameters were individually and simultaneously varied over their distributions.
With the intervention program and extrapolating over 10 years, there would be approximately 60,920 fewer influenza cases, 2,031 fewer pertussis cases, and 13,842 fewer pneumococcal illnesses in adults aged 65 and older. Total per-person vaccination and illness costs with the intervention were $23.93 higher than without the intervention, with a concurrent increase in effectiveness of 0.0031 QALYs, or $7,635 per QALY gained. In sensitivity analyses, no individual parameter variation caused the intervention to cost more than $50,000 per QALY gained.
Implementing an intervention based on the 4 Pillars Practice Transformation Program is a cost-effective undertaking in primary care practices for individuals aged 65 and older, with predicted public health benefits.
评估一项干预措施在基层医疗实践中提高65岁及以上成年人接种含肺炎球菌、流感和百日咳疫苗比例的成本效益。
马尔可夫决策分析模型,比较“四支柱实践转型计划”与无干预措施的成本效益。
美国两个城市的不同基层医疗实践机构。
65岁及以上的临床试验参与者。
质量调整生命年(QALYs)、公共卫生结果和成本。疫苗接种率和干预成本来自一项随机对照整群试验。其他参数来自医学文献和疾病控制与预防中心的数据。所有参数在其分布范围内单独且同时变化。
通过干预计划并推算10年,65岁及以上成年人中流感病例将减少约60,920例,百日咳病例减少2,031例,肺炎球菌疾病减少13,842例。干预组的人均疫苗接种和疾病总成本比无干预组高23.93美元,同时有效性增加0.0031个QALYs,即每获得一个QALY成本为7,635美元。在敏感性分析中,没有单个参数的变化导致干预措施每获得一个QALY的成本超过50,000美元。
在基层医疗实践中对65岁及以上人群实施基于“四支柱实践转型计划”的干预措施具有成本效益,且预计会带来公共卫生效益。